GM19694
LCL from B-Lymphocyte
Description:
GLYCOGEN STORAGE DISEASE VIII (IX, INCLUDED)
EHLERS-DANLOS SYNDROME, TYPE III
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases |
| Class |
Disorders of Carbohydrate Metabolism |
|
Biopsy Source
|
Peripheral vein
|
|
Cell Type
|
B-Lymphocyte
|
|
Tissue Type
|
Blood
|
|
Transformant
|
Epstein-Barr Virus
|
|
Sample Source
|
LCL from B-Lymphocyte
|
|
Race
|
White
|
|
Ethnicity
|
SCOTTISH/IRISH/ENGLISH
|
|
Family Member
|
3
|
|
Relation to Proband
|
son
|
|
Confirmation
|
Clinical summary/Case history
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase,Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
| |
| Remarks |
Clinically affected with GSD IX; at 9 months had cessation of growth, excess weight gain (75th percentile) and enlarged liver; treated with high protein diet and Viokase; weight was over 95% by 18 months and off the charts by age 30 months; weight gain began to drop at age 4; at age 6 years height and weight were normal; learning disability associated with spatial sequential issues; symptoms of Ehlers-Danlos syndrome hypermobility type include chronic joint pain in shoulders and knees, pes planus, and bilateral hiatal hernias; diagnosis of EDS has not been confirmed clinically; mother (GM19634) is clinically affected with EDS hypermobility type; clinically affected father is GM19687; 2 brothers clinically affected with GSD IX, including GM 19696; brother not clinically affected with GSD IX is GM19698; same donor as GM19693 Fibroblast |
| dbSNP |
dbSNP ID: 18904 |
| Gene Ontology |
GO:0004689 phosphorylase kinase activity |
|
GO:0005516 calmodulin binding |
|
GO:0005964 phosphorylase kinase complex |
|
GO:0005975 carbohydrate metabolism |
|
GO:0005977 glycogen metabolism |
|
GO:0006091 energy pathways |
|
GO:0006464 protein modification |
| NCBI Gene |
Gene ID:5256 |
| NCBI GTR |
130020 EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE; EDSHMB |
|
306000 GLYCOGEN STORAGE DISEASE IXa1; GSD9A1 |
| OMIM |
130020 EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE; EDSHMB |
|
306000 GLYCOGEN STORAGE DISEASE IXa1; GSD9A1 |
| Omim Description |
GLYCOGEN STORAGE DISEASE IX, INCLUDED |
| |
GLYCOGEN STORAGE DISEASE VIII |
| |
GLYCOGENOSIS VIIIA |
| |
HEPATIC PHOSPHORYLASE KINASE DEFICIENCY; PHK |
| |
LIVER GLYCOGENOSIS, X-LINKED, TYPE I |
| |
LIVER GLYCOGENOSIS, X-LINKED, TYPE II, INCLUDED; XLG2, INCLUDED |
| |
PHKA, INCLUDED |
| |
PHOSPHORYLASE KINASE DEFICIENCY OF LIVER; PYK; PYKL |
| |
X-LINKED LIVER GLYCOGENOSIS; XLGPHOSPHORYLASE KINASE, LIVER, ALPHA-2 SUBUNIT, INCLUDED; PHKA2, INCLUDED |
| Split Ratio |
1:4 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not Inactivated |
| Substrate |
None specified |
| Subcultivation Method |
dilution - add fresh medium |
| Supplement |
- |
|
|